The Cedars-Sinai Liver Research Program is made up of renowned physicians and specialist nurses who are dedicated to advancing the science and practice of hepatology.
The hepatology team at Cedars-Sinai is frequently sought out by physicians, scientists, and research and pharmaceutical companies to advise and participate in leading clinical studies. Cedars-Sinai has a broad range of fully funded research studies for patients with viral hepatitis and other liver diseases.
Clinical research trials allow patients access to the most up-to-date treatments and medications and also advance scientific knowledge. Cedars-Sinai's expert research nurses and physicians closely supervise the patients throughout the study, and access to medical care is available 24 hours a day. All studies are conducted under the Good Clinical Practice guidelines and approved by the Cedars-Sinai Institutional Review Board.
Currently enrolling studies for patients with hepatitis C or hepatitis B include those for people who are treatment naïve (diagnosed with viral hepatitis but have not been treated), nonresponders and relapsers (previously treated and the virus came back). We also have studies for post-liver-transplant patients with hepatitis.
If you are interested in participating in a study or would like to discuss treatment for liver disease, you can contact a research coordinator: